Fitbit has just vaulted over a huge hurdle: it can now continuously monitor users’ heart rhythms. This was authorized by the US’ Food and Drug Administration (FDA) — and takes the wearable company a ...

The Food and Drug Administration has given Fitbit the green light to monitor users' heart rhythms in the background. A new photoplethysmography (PPG) algorithm can passively check a user's heart ...

Google announced today that the U.S. Food and Drug Administration granted clearance for a long-awaited algorithm to detect atrial fibrillation (AFib) in users through select Fitbit smartwatches and ...

The U.S. Food and Drug Administration (FDA) has authorized a new Fitbit feature designed to continuously monitor a wearer’s heart rhythms for signs of atrial fibrillation. The roll-out is based on a ...

Rising rates of heart rhythm problems are colliding with an aging population and crowded hospitals. At the same time, many people still rely on bulky monitors and sticky disposable patches to track ...

Health tech: Fitbit's line of wearable watches might have started as simple step trackers, but their capabilities have expanded greatly over the years. The company now sells full smartwatches, and ...

This morning Fitbit landed FDA clearance for its long-awaited photoplethysmography atrial fibrillation (AFib) detection algorithm. The algorithm will be part of Fitbit's new Irregular Heart Rhythm ...

If you weren't already aware, Google acquired Fitbit back in November 2019 in a deal worth $2.1 billion. It signaled that Google was indeed serious about the wearables market despite having only made ...

Google has announced that the Food and Drug Administration (FDA) has cleared its product, Fitbit, to use a new feature that will identify atrial fibrillation (AFib). In a statement on Monday, Google ...

Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was ...

conditions affecting the heart muscle (cardiomyopathies and myocarditis). Around 920,000 people in the UK were living with heart failure in 2018 with an estimated 200,000 new diagnoses each year.